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See Article, pages 359–365Although Alice may have had things in mind other than bile
acids, it is her fascination with the remarkable nature of her sur-
roundings that leads to this exclamation in Lewis Carroll’s 1865
classic ‘‘Alice’s Adventures in Wonderland’’. In this same frame
of mind, although perhaps not as dreamily artful, we are learning
more and more about the intricacies and linkages between bile
acid ﬂux, intestinal biology, and the ever-expanding roles of bile
acids as signaling molecules that act directly and indirectly to
orchestrate biological crosstalk between intestine and liver.
In 1999, we learned that bile acids are gene regulators, acting
as strong and powerful ligands for several members of the
nuclear receptor superfamily [1] including FXR, PXR, LXR, VDR,
and others [2]. As potent ligands for FXR (NR1H4), bile acids reg-
ulate diverse biological pathways such as those involved in glu-
cose, amino acid and lipid metabolism, cell cycle progression,
drug detoxiﬁcation, bile acid synthesis, and the adaptive response
to cholestasis. In the latter capacity, bile acids, in ways that are
now known to extend beyond gene regulation through FXR, act
as both sensor and effector to autoregulate intracellular levels
of bile acids, to reduce inherent toxicities of intracellular bile acid
accumulation in hepatocytes. However, in the ensuing years,
since the discovery of bile acids as gene regulators, it has become
apparent that these autoregulatory pathways of bile acids in the
liver were not able to fully explain the complexities of the liver’s
response to bile acid retention within the same cell. There were
hints that there were complexities that involved regulatory mol-
ecules and pathways that were not nuclear receptor mediated,
and even involved speciﬁc intervention from its upstream neigh-
bor—the intestine. In fact, to the consternation of hepatologists
worldwide, it appears that the intestine is a great protector and
regulator of liver health through ﬁne-tuning bile acid homeosta-
sis in ways that require intestinal FXR [3].
One of those aspects of whole body bile acid regulation that
engages the intestine, and were difﬁcult to explain with bile
acids–FXR autoregulation in liver alone, is the following observa-
tion: while inhibition of apical intestinal bile acid uptake leads to
induction of hepatic bile acid synthesis, blocking intestinal bile
acid basolateral export (but keeping apical import) leads toJournal of Hepatology 20
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E-mail address: skarpen@emory.edu.suppression of hepatic bile acid synthesis. If it is just the return
of bile acids to the liver that directs the expression of genes
involved in hepatic bile acid synthesis, then one would presume
that both intestinal processes should lead to the same hepatic
outcome (i.e., reduced hepatic bile acid synthesis). However, such
is not the case and hepatic bile acid synthetic responses are truly
distinct when one blocks either intestinal apical import or baso-
lateral export. A simple explanation is elusive, but may, in fact,
rest on the enterocyte’s FXR-mediated responses to retained bile
acids within.
It is along these lines that Lan et al. in Dr. Paul Dawson’s labo-
ratory directed their energies to help explain these apparently
incongruous ﬁndings in a clear and important publication in this
issue of the Journal of Hepatology [4]. The group focused their
attention on mice where intestinal basolateral bile acid export is
inhibited due to genetic disruption of the Osta gene (Osta/,
whose product is a necessary component of a heterodimer respon-
sible for basolateral bile acid export from the intestine into the
portal circulation) [5,6]. Why these mice would have decreased
hepatic bile acid synthesis, and if it rests with FXR-mediated path-
ways, formed the focus of their studies, by comparing wild type
(WT) to Osta/ to FXR/ to Osta/FXR/ double knockout
mice (DKO).
Although there were several distinctions between the genetic
subtypes, a few essential and intriguing outcomes were seen in
both intestine and liver. Of note, the distal small intestine of
Osta/ and DKO mice was remarkably thicker, blunter, with
immature enterocyte morphology. There was also increased
mass, cell number, and nucleic acid content along a luminal dis-
tribution, in keeping with prominent bile acid uptake in the ter-
minal ileum. Why retention of bile acids leads to increased
intestinal mass in an FXR-independent fashion remains to be
determined.
For the liver, there were several notable changes, whereby the
main inducer of bile acid synthesis, Cyp7a1, was markedly sup-
pressed in Osta/ mice, but was substantially increased in
DKO mouse livers. Thus, the similar changes in intestinal mor-
phology did not have similar effects on liver bile acid gene
regulation.
However, there was a substantial difference in an FXR-respon-
sive gene in the ileum that is a main signaling molecule that sup-
presses hepatic Cyp7a1 (and other genes) after coursing through
the portal circulation—FGF15. Total FGF15 protein in the hyper-
trophied Osta/ ileal tissues was substantially higher (upwards12 vol. 57 j 237–238
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of 20) than in WT FXR/ and DKO mice. Intriguingly, ileal
FGF15 RNA levels were not substantially increased in these same
tissues, arguing for multi-layered regulation of this gene in these
tissues that weaves together alterations in bile acid uptake, chan-
ged FXR functions and expression, along with bile acid regulation
of other cell signaling pathways. Thus, there is both support, and
new questions, that point to roles that include, and in many ways
do not include, ileal FXR regulation by retained bile acids. This is
an intriguing process that requires additional studies to tease
apart the relevant contributors.
There are several unanswered questions uncovered by these
careful studies. The lack of substantial ileal bile acid retention
in Osta/ mice suggests either a counter-regulatory process
(e.g., reduced apical bile acid uptake seen in these samples) or,
perhaps, new hormones or regulatory molecules as yet unnamed.
The actual mechanisms leading to ileal hyperplasia and why
these do not include FXR is also quite intriguing. What is clear
is that bile acids, and their evolutionary roles in ileal and hepatic
biology, have many secrets waiting to be discovered. Researchers
like Tan et al. are likely to provide novel insights into the com-
plexities of liver and intestinal biology to help those of us grap-
pling with the reasons for these linked homeostatic responses
[7]. In the near future, it is anticipated that our understanding
of bile acid biology will be curiouser and curiouser, but also will
certainly be a lot clearer.238 Journal of Hepatology 201Conﬂict of interest
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